1. Home
  2. ABUS vs BZH Comparison

ABUS vs BZH Comparison

Compare ABUS & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.68

Market Cap

839.5M

Sector

Health Care

ML Signal

HOLD

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

N/A

Current Price

$33.13

Market Cap

767.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
ABUS
BZH
Founded
2005
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
839.5M
767.3M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
ABUS
BZH
Price
$4.68
$33.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$32.00
AVG Volume (30 Days)
1.3M
668.6K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
55.26
N/A
EPS
0.84
N/A
Revenue
$14,083,000.00
$2,087,739,000.00
Revenue This Year
N/A
$4.36
Revenue Next Year
$239.71
$10.79
P/E Ratio
$5.45
N/A
Revenue Growth
128.21
N/A
52 Week Low
$3.35
$17.83
52 Week High
$5.38
$34.54

Technical Indicators

Market Signals
Indicator
ABUS
BZH
Relative Strength Index (RSI) 56.21 58.85
Support Level $4.11 $31.67
Resistance Level $4.82 $34.16
Average True Range (ATR) 0.15 0.63
MACD 0.03 -0.22
Stochastic Oscillator 92.39 49.57

Price Performance

Historical Comparison
ABUS
BZH

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

Share on Social Networks: